Loading news...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Acuity (NYSE: AYI - Get Free Report) and Edenred (OTCMKTS:EDNMY - Get Free Report) are both mid-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Acuity has a beta of
Edenred now trades at 8x P/E and offers a 7% dividend yield, presenting a compelling risk-reward profile despite regulatory headwinds. The business model is asset-light highly cash-generative and boasts a 20.84% net margin with €1,111 million in free cash flow for 2025. Edenred's core offering—tax-advantaged meal vouchers and gift cards—anchors it in markets with favorable tax laws, though this limits geographic expansion.
EDENRED (EDNMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Edenred SE (EDNMY) Q4 2025 Earnings Call Transcript
Shares of Edenred (OTCMKTS:EDNMY - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $10.00, but opened at $10.75. Edenred shares last traded at $10.40, with a volume of 840 shares. Analysts Set New Price Targets Several research analysts have recently issued reports on the company. Zacks
Edenred (OTCMKTS:EDNMY - Get Free Report) has received an average recommendation of "Hold" from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and one has issued a buy recommendation on the company. A
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Edenred SE (OTC:EDNMY) Analyst/Investor Day November 4, 2025 8:00 AM EST Company Participants Bertrand Dumazy - Chairman & CEO Constance Le Bouar - Executive Vice President of Strategy, Marketing & Transformation Damien Perillat - Chief Operating Officer of Payment Solutions & New Markets Clément Le Chatelier Arnaud Erulin - Chief Operating Officer of Benefits & Engagement Diane Coliche - Chief Operating Officer of Mobility Virginie J. Duperat-Vergne - Executive Vice President of Finance Cedric Appert - Financial Communication & Investor Relations Director and Employee-Representative Director Conference Call Participants Edward Young - Morgan Stanley, Research Division Justin Forsythe - UBS Investment Bank, Research Division Sabrina Blanc - Sanford C.
Oakmark International Strategy portfolio's return was 4.09% (net) for the reporting period versus MSCI World ex USA Index that returned 5.33% for the same period. Alibaba Group's stock price rose significantly following earnings that reflected rapid Chinese AI growth. CNH Industrial's stock price declined as it delivered weak results but reaffirmed guidance amidst a difficult environment.
Edenred SE (OTC:EDNMY) Q3 2025 Sales Call October 21, 2025 2:30 AM EDT Company Participants Virginie J. Duperat-Vergne - Executive Vice President of Finance Cedric Appert - Financial Communication & Investor Relations Director and Employee-Representative Director Conference Call Participants Andre Juillard - Deutsche Bank AG, Research Division Edward Young - Morgan Stanley, Research Division Josh Levin Julien Richer - Kepler Cheuvreux, Research Division Hannes Leitner - Jefferies LLC, Research Division Justin Forsythe - UBS Investment Bank, Research Division Kate Xiao - BofA Securities, Research Division Pravin Gondhale - Barclays Bank PLC, Research Division Estelle Weingrod - JPMorgan Chase & Co, Research Division Presentation Operator Welcome to the Edenred Q3 2025 Revenue Conference Call.
Edenred offers a wide-moat business at a significant discount, trading at 10x 2025E EPS versus a historical 30-40x multiple. Despite regulatory threats in France, Italy, and Brazil, EDNMY's strong market position, diversification, and tech investments support continued growth and resilience. Recent acquisitions and management's disciplined strategy have maintained robust returns on capital, with CEO Bertrand Dumazy driving digital transformation and prudent expansion.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EDNMY, THC and MBWM made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 25, 2025.
Edenred SE (OTC:EDNMF) H1 2025 Earnings Conference Call July 23, 2025 2:30 AM ET Company Participants Bertrand Dumazy - Chairman & CEO Virginie J. H. Duperat-Vergne - Executive Vice President of Finance Conference Call Participants Edward Young - Morgan Stanley, Research Division Estelle Weingrod - JPMorgan Chase & Co, Research Division Hannes Leitner - Jefferies LLC, Research Division Josh Levin - Autonomous Julien Richer - Kepler Cheuvreux, Research Division Justin Thomas Forsythe - UBS Investment Bank, Research Division Mourad Lahmidi - BNP Paribas Exane, Research Division Pravin Gondhale - Barclays Bank PLC, Research Division Operator Hello, and welcome to the Edenred Half Year 2025 Call.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Edenred is a French company and a leader in employee benefit and mobility payment programs. It's a high-quality business, but the share price has plummeted due to fears over regulation in its two most important markets, Brazil and Italy. The shares are trading at a discount to its intrinsic value, compared to peers and at low multiples.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.